Safety of Argatroban Infusion in Conduction Disturbances

Inclusion Criteria: * Diagnosis of stable CAD or unstable angina (troponin negative, i.e. within the normal range for the study site) with low to moderate anatomic risk. * Patient required elective percutaneous coronary angioplasty or stent insertion with an approved device in one or more de novo-treated or re-stenotic lesions in native vessels. * Patient was on adequate platelet inhibition therapy after having received a loading dose with ASA and clopidogrel before start of intervention (this additional inclusion criterion was introduced with study protocol version 1.6, dated 14.12.2018) * Willingness to give written informed consent, written consent for data protection (legal requirement in Germany "datenschutzrechtliche Einwilligung") and willingness to participate and to comply with the requirements of the study protocol. * The patient (female/male) was at least 18 years of age. * Baseline ECG without changes that impair assessment of QTc interval. Exclusion Criteria: * Patient was indicated for highly complex 3-vessel intervention. * The female patient was pregnant (exclusion by routine urine test) or was nursing during therapy period. * Patients who were currently participating in another clinical trial or patients who participated in another clinical trial during the last 3 months prior to study start (date of treatment visit). * History of drug, alcohol or chemical abuse within 6 months prior to study start. * Planned surgical intervention other than study procedur…